eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2022
vol. 47
 
Share:
Share:
abstract:
Clinical immunology

Implementation of TREC/KREC detection protocol for newborn SCID screening in Bulgaria: a pilot study

Marina Marinova
1
,
Atanaska Georgyeva
2
,
Viktoriya Yordanova
3
,
Nedelcho Ivanov
2
,
Valentina Atanasova
2
,
Elissaveta Naumova
1, 2
,
Snezhina Mihailova Kandilarova
1, 2

  1. Department of Clinical Immunology, Medical University Sofia, Bulgaria
  2. Clinic of Clinical Immunology with Stem Cell Bank, Alexandrovska University Hospital, Sofia, Bulgaria
  3. National Genetics Laboratory, University Hospital of Obstetrics and Gynecology “Maichin dom”, Medical University Sofia, Bulgaria
Cent Eur J Immunol 2022; 47 (4): 339-349
Online publish date: 2023/01/31
View full text Get citation
 
PlumX metrics:
Neonatal screening for inborn errors of immunity (IEI), based on quantification of T-cell-receptor- excision circles (TRECs) and kappa-deleting recombination-excision circles (KRECs) from dried blood spots (DBS), allows early diagnosis and improved outcomes for the affected children.

Determination of TREC/KREC levels from prospectively collected newborns’ Guthrie cards and from DBS samples of patients with confirmed IEI was done using a commercial kit. Retrospective assessment of flow cytometry evaluation of TREC/KREC correspondence with lymphocyte subpopulations and evaluation of the correlations between TREC and KREC with immune cells, based on the data from patients with suspected or confirmed immune disorders, were conducted.

2,228 Guthrie cards were tested, 1276 for TREC only and 952 for both TREC and KREC. Eight newborns (0.36%) were TREC positive and 10 (1.05%) had KREC below the cut-off. The re-testing rate was 1.88%. Retrospective analysis demonstrated that the TREC/KREC assay identifies 100% of severe combined immune deficiencies (SCID) cases when DBS were collected at birth. Correlation analysis showed moderate significant correlations between TREC and the absolute numbers of CD4 cells (r = 0.634, p < 0.01) and total T cells (r = 0.536, p < 0.01). The ability of KREC levels to predict abnormal absolute (AUC of 0.772) and relative (AUC 0.731) levels of B cells was demonstrated.
keywords:

TREC, SCID, newborn screening, IEI, KREC

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.